Health & Biotech
Health & Biotech
The next Neuren? These ASX biotech stocks have pending FDA catalysts in 2024
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
News
Hot Money Monday: Beware of ‘mean reversion’ as Compumedics, Fatfish surge on momentum
News
ASX Small Caps and IPO Weekly Wrap: Lotsa pushin’ and shovin’, not a whole lotta movin’
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: Iron ore, oil fields and medical diagnostics deals
News
Closing Bell: Maximus and Jupiter rising; Tech tops ASX after Bitcoin bags ETF
News
Market Highlights: SEC approves these 11 Bitcoin ETFs overnight, and 5 small caps to watch today
Health & Biotech
ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024
Experts
SUNDAY ROAST: The stocks that lit a fire under our experts this week
Experts
For Die Hard Investors: Luke’s trio of high-risk small caps Most Likely to Survive Nakatomi Plaza in 2024
Health & Biotech
Check Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winners
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX highest it’s been in three months
News
ASX Small Caps Lunch Wrap: Guess who’s got a stomach-churning spider story for you all today?
Health & Biotech
ASX Health Stocks: Island Pharma advances anti-viral study; Compumedics scores $9.3m order in China
News
